DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore
NCT03291821 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136
Last updated 2020-12-29
Summary
Since preimplantation genetic testing (PGT) is being more frequently requested from patients as women pursue infertility treatments at an advanced age with a poorer prognosis, sometimes physicians are compelled to perform several stimulation cycles to obtain more eggs and, consequently, a greater number of biopsied embryos. Hence, the idea of carrying out this study arises as an attempt to optimize each menstrual cycle to the maximum.
It is believed that the double stimulation (DuoStim) protocol could be an alternative for this group of patients, allowing to obtain a larger number of oocytes in a shorter period, thus, increasing the number of biopsied embryos and possibly decreasing the interval to achieve a successful pregnancy.
The investigators aim to evaluate the potential usefulness of the DuoStim protocol for patients desiring to obtain oocytes as soon as possible. Using PGT, the investigators will compare the rate of euploid embryos per cycle in patients undergoing DuoStim protocol versus patients undergoing two conventional controlled ovarian hyperstimulation in consecutive cycles. Patients will include women with advanced age and poor response.
This is a unicentric, prospective, randomized, non-blind, parallel-group controlled phase IV clinical study. The investigators hypothesize that the rate of euploid embryos per cycle is similar in the DuoStim group compared to the group undergoing two conventional controlled ovarian hyperstimulation in consecutive cycles.
Furthermore the investigators will evaluate if there are differences regarding the number of total oocytes obtained, the number of mature oocytes, the number of biopsied blastocysts and the MitoScore index of the available euploid embryos.
Conditions
- Infertility, Female
Interventions
- DRUG
-
human menopausal gonadotropin
human menopausal gonadotropin subcutaneously
- DRUG
-
GnRH antagonist
GnRH antagonist subcutaneously
- DRUG
-
GnRH analog
GnRH analog subcutaneously
- PROCEDURE
-
Trophectoderm biopsy
Trophectoderm biopsy is the process of removing few cells from an in vitro fertilization embryo.
- DIAGNOSTIC_TEST
-
MitoScore
The cells removed from an in vitro fertilization embryo during the trophectoderm biopsy will be used to assess the mitochondrial DNA content as a viability indicator in the euploid embryos.
- PROCEDURE
-
Intracytoplasmic sperm injection
ICSI is an in vitro fertilization procedure in which a single sperm is injected directly into an oocyte.
- PROCEDURE
-
Ovarian puncture
Egg retrieval is a simple procedure. It is performed in an operating room for safety reasons. It is performed vaginally and involves aspirating the follicular fluid through a thin needle. Embryologists then retrieve from this fluid the eggs that have matured during stimulation. It lasts for 5 to 15 minutes, and a mild sedative is administered to prevent any kind of pain during the procedure.
- DIAGNOSTIC_TEST
-
Preimplantation genetic test
The cells removed from an in vitro fertilization embryo during the trophectoderm biopsy will be tested for chromosomal normalcy before transferring the embryo to the uterus.
- PROCEDURE
-
Embryo transfer
Embryo transfer refers to a step in the process of assisted reproduction in which embryos are placed into the uterus
- DIAGNOSTIC_TEST
-
Pregnancy test
A pregnancy test is used to determine whether a woman is pregnant.
- PROCEDURE
-
Embryo freezing
Embryo freezing is a method for cryopreserving embryos.
- PROCEDURE
-
Embryo thawing
Embryo thawing is the procedure to recover previously frozen embryos prior to an embryo transfer.
Sponsors & Collaborators
-
IVI Madrid
lead OTHER
Principal Investigators
-
Maria Cerrillo, M.D., Ph.D. · IVI Madrid
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 42 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2019-12-01
- Completion
- 2020-06-01
Countries
- Spain
Study Locations
More Related Trials
-
Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation.
NCT00365027 ·Status: WITHDRAWN ·Phase: NA
-
Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality
NCT03139474 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Gonadotropin Type in Ovarian Stimulation
NCT02437032 ·Status: COMPLETED ·Phase: PHASE4
-
Difference Between Progestin Primed Ovarian Stimulation Protocol and Antagonist Protocol
NCT06738602 ·Status: NOT_YET_RECRUITING
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
NCT06212102 ·Status: RECRUITING ·Phase: PHASE2
-
Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer
NCT07269392 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
NCT05969795 ·Status: RECRUITING ·Phase: PHASE1
-
Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders
NCT04537078 ·Status: COMPLETED ·Phase: PHASE3
-
Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure
NCT02329197 ·Status: UNKNOWN ·Phase: PHASE4
-
Cumulative Live Birth After Double Stimulation Protocol Versus Antagonist Protocol for Poor Ovarian Responders
NCT05765968 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
NCT01669291 ·Status: COMPLETED ·Phase: NA
-
Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
NCT01044862 ·Status: COMPLETED ·Phase: PHASE3
-
Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme
NCT05759871 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Trigger Timing in Ovarian Stimulations
NCT04163133 ·Status: RECRUITING ·Phase: NA
-
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
NCT01331733 ·Status: COMPLETED
-
Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation
NCT02703584 ·Status: COMPLETED ·Phase: PHASE4
-
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
NCT04108039 ·Status: COMPLETED ·Phase: NA
-
Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF
NCT02070198 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles
NCT04008966 ·Status: COMPLETED ·Phase: PHASE4
-
Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Embryo Transfer on Pregnancy Outcomes in Frozen Embryo Transfer Cycles.
NCT02825108 ·Status: COMPLETED ·Phase: PHASE3
-
Endometrial Preparation in Frozen Embryo Transfer Cycles
NCT03540979 ·Status: UNKNOWN ·Phase: NA
-
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
NCT00669786 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of hCG on Receptivity of the Human Endometrium
NCT01786252 ·Status: COMPLETED ·Phase: PHASE4
-
Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome
NCT05638529 ·Status: UNKNOWN ·Phase: PHASE4